View Older Stories View More Recent Stories

Mar 29, 2026 10:00AM Should you buy the dip in Novo Nordisk stock? Wall Street analyst answers

Mar 27, 2026 09:01AM Lilly presents four-year data for EBGLYSS in atopic dermatitis study

Mar 27, 2026 08:32AM Morgan Stanley on Eli Lilly (LLY) following scripts: 'We see ~6% upside to '26 M+Z ests'

Mar 27, 2026 08:16AM Jefferies on Eli Lilly (LLY) competition: Oral Wegovy's TRx came in at ~94.7k on IMS & ~80.1k on Symphony

Mar 25, 2026 06:16AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put

Mar 24, 2026 09:45AM Lilly gets FTC clearance for Innovent Biologics acquisition

Mar 23, 2026 09:34AM Takeda, Lilly rejected by Supreme Court on Actos fraud lawsuit

Mar 20, 2026 08:14AM Jefferies: Oral Wegovy Outpacing Injectables; Lilly (LLY) Well-Positioned Ahead of April PDUFA

Mar 20, 2026 07:31AM India's Eris Lifesciences launches generic semaglutide at $13.8 per month

Mar 19, 2026 02:52PM Leerink Partners on Eli Lilly (LLY) following Retatrutide data

Mar 19, 2026 10:17AM BMO on Eli Lilly (LLY): 'Triple Agonist Turns Double Play - Extending Positive Results to Both T2D and OA'

Mar 19, 2026 10:14AM Morgan Stanley on Eli Lilly (LLY): retatrutide weight loss data 'encouraging,' but offset by GI adverse events

Mar 19, 2026 09:08AM Truist Securities on Eli Lilly (LLY): retatrutide ph3 results 'favorable' but similar data to Mounjaro

Mar 19, 2026 08:31AM Wolfe Research on Eli Lilly (LLY): ph3 retratrutide results point to potential 'best-in-class' weight loss

Mar 18, 2026 09:11AM UBS Reiterates Buy Rating on Eli Lilly (LLY) Following Strong Q4, Upside Guidance

Mar 17, 2026 09:51AM HSBC downgrades Eli Lilly, says shares are 'priced to perfection'

Mar 17, 2026 03:33AM HSBC Downgrades Eli Lilly (LLY) to Reduce

Mar 16, 2026 10:32AM Leerink on Structure Therapeutics (GPCR): 'Oral GLP-1 Achieves Best-In-Class Weight Loss'

Mar 16, 2026 10:25AM RBC: 'Our focus for LLY remains on the pending Orfo approval and subsequent launch'

Mar 13, 2026 08:09AM Jefferies Reiterates Buy Rating on Eli Lilly (LLY): 'early oral Wegovy launch is directionally encouraging'

Mar 11, 2026 06:39AM Eli Lilly to invest $3 billion in China, seeks approval for new GLP-1 drug

Mar 10, 2026 08:10PM Hims & Hers hires ex-Eli Lilly PR chief Beiser as top communications officer

Mar 10, 2026 08:08AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY)

Mar 9, 2026 12:23PM TD Cowen: 'Wegovy Injection may be declining'

Mar 9, 2026 07:33AM Amazon Pharmacy adds Eli Lilly's Zepbound KwikPen with $299 pricing

Mar 6, 2026 10:39AM Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY) following aggregate scripts

Mar 6, 2026 08:28AM Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY): "We see ~7% upside to '26 M+Z ests"

Mar 5, 2026 08:04AM Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY) following Employer Connect launch

Mar 5, 2026 06:02AM Lilly launches employer platform for obesity drug access with 15 administrators

Mar 3, 2026 04:02PM FDA issues 30 warning letters to telehealth firms over GLP-1 claims

Feb 27, 2026 08:13AM CHMP recommends Eli Lilly's Olumiant for teens with severe hair loss

Feb 26, 2026 06:30AM Eli Lilly's orforglipron outperforms oral semaglutide in diabetes trial

Feb 25, 2026 08:22AM Bernstein Weighs In on Eli Lilly (LLY) Amid 'Risk of a Price War'

Feb 24, 2026 04:06PM RBC Capital Starts Eli Lilly (LLY) at Outperform

Feb 24, 2026 10:11AM BofA on Eli Lilly (LLY): 'Novo’s GLP-1 price update unlikely to ‘rock the boat’'

Feb 24, 2026 07:48AM Eli Lilly falls 2% on Novo Nordisk price cut plans

Feb 24, 2026 07:41AM Novo To Cut Ozempic, Wegovy's US List Prices By Up To 50% - WSJ

Feb 24, 2026 07:31AM Novo Nordisk To Cut Ozempic List Price By 34% - WSJ

Feb 23, 2026 09:00AM Eli Lilly launches multi-dose KwikPen for Zepbound weight management drug

Feb 23, 2026 05:56AM Novo Nordisk's CagriSema fails to match tirzepatide in obesity trial

Feb 23, 2026 05:40AM Novo Nordisk (NVO) -13% after 'worst case' REDEFINE-4 readout; LLY +4%

Feb 23, 2026 05:18AM Eli Lilly & Co. (LLY) call put ratio 1.1 calls to 1 put into share price up before the bell

Feb 20, 2026 05:59AM Barclays Starts Eli Lilly (LLY) at Overweight

Feb 19, 2026 12:16PM Lilly's Omvoh shows sustained remission in Crohn's disease study

Feb 18, 2026 06:45AM Eli Lilly's psoriasis and obesity drugs show superior results in trial

Feb 13, 2026 08:30AM This pharma stock is 'poised to outperform in 2026,' Wolfe says

Feb 10, 2026 03:24PM Freedom Capital Markets Upgrades Eli Lilly (LLY) to Buy

Feb 10, 2026 10:27AM UBS Reiterates Buy Rating on Eli Lilly (LLY), Bullish on Orfo

Feb 10, 2026 08:57AM BMO Capital: 'Eli Lilly (LLY) to Expand Into in Vivo CAR-T Space With Acquisition of Orna'

Feb 9, 2026 08:26AM Hims and Hers (HIMS) PT Lowered to $20 at Leerink Partners

View More Recent Stories View Older Stories